We are live on ! Find out more
OppenheimerFunds

OppenheimerFunds Portfolio holdings

AUM $80.4B Turnover 10.91%
1-Year Est. Return 15.1%

OppenheimerFunds's holdings are now reported by Invesco.

This Fund
S&P 500
This Quarter Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.06%
5 Year Est. Return
+90.98%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
Cap. Flow
-$1.63B
Cap. Flow %
-2.03%
Top 10 Hldgs %
17.35%
Holding
1,869
New
80
Increased
811
Reduced
838
Closed
124
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.9 years

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$291M
2
PEP icon
PepsiCo
PEP
+$260M
3
BNY icon
Bank of New York Mellon
BNY
+$258M
4
AAPL icon
Apple
AAPL
+$221M
5
WES icon
Western Gas Partners
WES
+$215M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.13%
2 Technology 15.85%
3 Healthcare 13.96%
4 Energy 13.9%
5 Financials 12.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KO icon
101
Coca-Cola
KO
$417B
$197M 0.25%
4,207,074
+226,599
+6% +$10.6M
2013 Q2
23 quarters
AM icon
102
Antero Midstream
AM
$9.32B
$194M 0.24%
14,061,306
+6,655,328
+90% +$86.9M
2017 Q2
7 quarters
DCP
103
DELISTED
DCP Midstream
DCP
$188M 0.23%
5,679,044
+826,841
+17% +$26.4M
2013 Q2
23 quarters
QCOM icon
104
Qualcomm
QCOM
$160B
$184M 0.23%
3,221,596
+1,052,071
+48% +$56.8M
2013 Q2
23 quarters
ULTA icon
105
Ulta Beauty
ULTA
$26.3B
$182M 0.23%
522,251
-162,028
-24% -$49M
2017 Q2
7 quarters
NWL icon
106
Newell Brands
NWL
$2.26B
$179M 0.22%
11,695,108
+1,017,861
+10% +$18.7M
2013 Q2
23 quarters
FDC
107
DELISTED
First Data
FDC
$179M 0.22%
6,798,567
-8,665,151
-56% -$206M
2015 Q4
13 quarters
T icon
108
AT&T
T
$150B
$178M 0.22%
5,671,731
-28,991
-0.5% -$883K
2013 Q2
23 quarters
BAC icon
109
Bank of America
BAC
$325B
$174M 0.22%
6,300,608
-447,165
-7% -$12.6M
2013 Q2
23 quarters
XOM icon
110
ExxonMobil
XOM
$653B
$173M 0.22%
2,142,721
+907,448
+73% +$69.2M
2013 Q2
23 quarters
AZN icon
111
AstraZeneca
AZN
$270B
$166M 0.21%
2,052,645
+1,201,960
+141% +$94.7M
2017 Q2
7 quarters
HEP
112
DELISTED
Holly Energy Partners
HEP
$165M 0.2%
6,104,996
-162,067
-3% -$4.71M
2013 Q2
23 quarters
IONS icon
113
Ionis Pharmaceuticals
IONS
$4.43B
$165M 0.2%
2,027,449
+7,323
+0.4% +$472K
2015 Q4
13 quarters
CRM icon
114
Salesforce
CRM
$149B
$164M 0.2%
1,034,588
-74,389
-7% -$11.5M
2015 Q4
13 quarters
AMRN icon
115
Amarin
AMRN
$444M
$163M 0.2%
392,706
-1,757
-0.4% -$634K
2015 Q3
14 quarters
DOX icon
116
Amdocs
DOX
$4.3B
$159M 0.2%
2,931,073
-1,008,210
-26% -$56.7M
2013 Q2
23 quarters
APU
117
DELISTED
AmeriGas Partners
APU
$158M 0.2%
5,127,675
+208,134
+4% +$6.09M
2013 Q2
23 quarters
NTAP icon
118
NetApp
NTAP
$31B
$158M 0.2%
2,273,957
+157,272
+7% +$10.2M
2015 Q4
13 quarters
SPH icon
119
Suburban Propane Partners
SPH
$1.1B
$157M 0.2%
7,015,333
+1,171,533
+20% +$25.9M
2013 Q2
23 quarters
ENLC icon
120
DELISTED
EnLink Midstream
ENLC
$156M 0.19%
12,168,263
+12,134,883
+36,354% +$137M
2017 Q4
5 quarters
CNC icon
121
Centene
CNC
$31.6B
$150M 0.19%
2,827,505
-1,169
-0% -$71K
2013 Q3
22 quarters
INCY icon
122
Incyte
INCY
$23.4B
$149M 0.19%
1,737,259
+7,215
+0.4% +$587K
2018 Q3
2 quarters
ALGN icon
123
Align Technology
ALGN
$10.9B
$148M 0.18%
522,069
-7,385
-1% -$1.76M
2015 Q4
13 quarters
SAVE icon
124
DELISTED
Spirit Airlines
SAVE
$148M 0.18%
2,807,700
+440,339
+19% +$25.3M
2013 Q3
22 quarters
MO icon
125
Altria Group
MO
$125B
$146M 0.18%
2,544,226
+708,894
+39% +$36.2M
2014 Q1
20 quarters

Similar funds

OppenheimerFunds's Q1 2019 Portfolio in Review

As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

OppenheimerFunds's Q1 2019 filing shows 80 new, 811 increased, 838 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
  • OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
  • OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
  • OppenheimerFunds fully exited Western Gas Partners in Q1 2019, selling an estimated $215M.
  • OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
  • OppenheimerFunds opened 80 new positions and closed 124 in Q1 2019.
  • OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.